Display options
Cite
Young WB. Allodynia as a complication of migraine: background and management. Curr Treat Options Neurol. 2009;11(1):3-9doi: 10.1007/s11940-009-0001-0.
Young, W. B. (2009). Allodynia as a complication of migraine: background and management. Current treatment options in neurology, 11(1), 3-9. https://doi.org/10.1007/s11940-009-0001-0
Young, William B. "Allodynia as a complication of migraine: background and management." Current treatment options in neurology vol. 11,1 (2009): 3-9. doi: https://doi.org/10.1007/s11940-009-0001-0
Young WB. Allodynia as a complication of migraine: background and management. Curr Treat Options Neurol. 2009 Jan;11(1):3-9. doi: 10.1007/s11940-009-0001-0. PMID: 19094830.
Copy Download .nbib Format: NLM
Share it on

Curr Treat Options Neurol. 2009 Jan;11(1):3-9. doi: 10.1007/s11940-009-0001-0.

Allodynia as a complication of migraine: background and management.

Current treatment options in neurology

William B Young

Affiliations

  1. William B. Young, MD Department of Neurology, Thomas Jefferson University Hospital, Jefferson Headache Center, 111 South Eleventh Street, Gibbon Building, Suite #8130, Philadelphia, PA 19107, USA. [email protected].

PMID: 19094830 DOI: 10.1007/s11940-009-0001-0

Abstract

Allodynia is a normal part of the untreated migraine attack in most people with episodic migraine and is prevalent in chronic migraine. The extent to which allo-dynia contributes to the pain and disability of migraine attacks is unclear, as is its clinical importance. The presence of allodynia correlates with the severity and other features of migraine, including aura, migraine-associated symptoms, and motor symptoms. The development of allodynia is associated with resistance to triptan treatment. It is uncertain whether this treatment resistance is due to the accompanying increase in headache severity or whether the development of allo-dynia is the fundamental biologic event causing the new treatment-refractory state. Animal models support the relationship to allodynia. Intravenous ketorolac may be effective at treating migraine with allodynia several hours after the development of the throbbing pain, but prior treatment with opioid analgesics may confer treatment resistance. Occipital nerve blocks rapidly treat migraine pain and allodynia. Uncontrolled studies have successfully used dihydroergotamine to treat episodic and chronic migraine with allodynia.

References

  1. Ann Neurol. 2004 Jan;55(1):27-36 - PubMed
  2. Ann Neurol. 2004 Jan;55(1):19-26 - PubMed
  3. Cephalalgia. 2007 Apr;27(4):325-9 - PubMed
  4. J Neurol Neurosurg Psychiatry. 2007 Jun;78(6):600-4 - PubMed
  5. AMA Arch Intern Med. 1953 Oct;92(4):478-84 - PubMed
  6. Ann Neurol. 2000 May;47(5):614-24 - PubMed
  7. Headache. 2007 Apr;47(4):531-9 - PubMed
  8. Headache. 2008 Feb;48(2):194-200 - PubMed
  9. Cephalalgia. 2008 Jan;28(1):87-91 - PubMed
  10. Neurology. 2008 Apr 22;70(17):1525-33 - PubMed
  11. Cephalalgia. 2006 Jul;26(7):852-6 - PubMed
  12. J Headache Pain. 2007 Feb;8(1):13-8 - PubMed
  13. Ann Neurol. 2008 Feb;63(2):148-58 - PubMed
  14. Headache. 2005 Jul-Aug;45(7):850-61 - PubMed
  15. Headache. 2005 Apr;45(4):350-4 - PubMed
  16. J Neurol Neurosurg Psychiatry. 1960 Feb;23:23-32 - PubMed
  17. Cephalalgia. 2006 Feb;26(2):113-21 - PubMed
  18. Neurology. 2004 Sep 14;63(5):848-52 - PubMed
  19. Curr Pain Headache Rep. 2006 Jun;10(3):231-8 - PubMed
  20. J Neurophysiol. 1998 Feb;79(2):964-82 - PubMed
  21. Headache. 2005 Sep;45(8):999-1003 - PubMed
  22. Headache. 2007 Sep;47(8):1219-23 - PubMed
  23. Neurol Sci. 2008 May;29 Suppl 1:S152-4 - PubMed
  24. Cephalalgia. 2007 Feb;27(2):111-7 - PubMed
  25. Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4274-9 - PubMed
  26. Brain. 2000 Aug;123 ( Pt 8):1703-9 - PubMed
  27. Headache. 2007 Jun;47(6):878-85 - PubMed
  28. Headache. 2008 Feb;48(2):248-58 - PubMed
  29. Headache. 2008 Jul;48(7):1126-8 - PubMed
  30. Cephalalgia. 2008 Oct;28(10):1095-105 - PubMed

Publication Types